Results 161 to 170 of about 19,922 (207)

Effects of antidepressant medications on brain tissue microstructure in persistent depressive disorder across two randomized controlled trials. [PDF]

Neuroimage Clin
Bansal R, Hellerstein DJ, Sawardekar S, Chen Y, Peterson BS.   +4 more
europepmc   +1 more source

Comparative Sleep Architecture Profiles of Antidepressants in Mice: Pharmacological Characterization of Paroxetine, Sertraline, Duloxetine, Mirtazapine and Vortioxetine. [PDF]

Pharmacol Res Perspect
Maruoka J, Egami R, Akita Y, Kozuka K, Kakumoto Y, Kikuchi T, Kume K.   +6 more
europepmc   +1 more source

Comparative risk of depressive disorder in patients with diabetic neuropathy treated with gabapentin versus duloxetine: Retrospective cohort study. [PDF]

J Family Community Med
Zerefos I, Joshi A, Namous F, Espiridion E.   +3 more
europepmc   +1 more source

Duloxetine: a review

Expert Review of Neurotherapeutics, 2003
A developing concept is that antidepressant strategies which combine multiple mechanisms of action may have advantages over agents with single mechanisms. Duloxetine is a novel potent dual reuptake inhibitor of noradrenaline and serotonin. The antidepressant efficacy of duloxetine is reviewed in three trials.
Michael Berk (13060851)
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Duloxetine

Clinical Pharmacokinetics, 2011
Mary Pat Knadler
exaly   +6 more sources